Antiplatelet effect of Z-335, a new orally active and long-lasting thromboxane receptor antagonist

By Tanaka T.   Fukuta Y.   Higashino R.   Sato R.   Nomura Y.   Fukuda Y.   Ito S.   Takei M.   Kurimoto T.   Tamaki H.  

European Journal of Pharmacology, Vol. 357, Iss. 1, 1998-09 ,pp. : 53-60

Elsevier

Access to resources Recommend Favorite

ATP-Dependent Transport of a Novel Thromboxane A₂ Receptor Antagonist, [2-(4-Chlorophenylsulfonylaminomethyl)-Indan-5-yl]Acetate (Z-335) and Its Xenobiotic Taurine Conjugate (Z-335-Tau) by Rat Bile Canalicular Membrane Vesicles

By Kawabata Yoshihiro   Kamada Emiko   Furuta Shigeru   Takei Mineo   Kurimoto Tadashi   Okudaira Kazuho   Nishigaki Ryuichiro  

Pharmaceutical Research, Vol. 21, Iss. 3, 2004-03 ,pp. : 467-475

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacological characterization of EK112, a new combined angiotensin II and thromboxane A 2 receptor antagonist

By Hwang T.-L.   Yeh Y.-A.   Chern J.-W.   Teng C.-M.  

General Pharmacology, Vol. 34, Iss. 1, 2000-01 ,pp. : 25-31

Elsevier

Access to resources Recommend Favorite

Antithrombotic activity of AT-1015, a potent 5-HT 2A receptor antagonist, in rat arterial thrombosis model and its effect on bleeding time

By Kihara H.   Koganei H.   Hirose K.   Yamamoto H.   Yoshimoto R.  

European Journal of Pharmacology, Vol. 433, Iss. 2, 2001-12 ,pp. : 157-162

Elsevier

Access to resources Recommend Favorite

G 619, a dual thromboxane synthase inhibitor and thromboxane A 2 receptor antagonist, inhibits tumor necrosis factor- biosynthesis

By Altavilla D.   Squadrito F.   Canale P.   Ioculano M.   Squadrito G.   Campo G.M.   Serrano M.   Sardella A.   Urna G.   Spignoli G.   Caputi A.P.  

European Journal of Pharmacology, Vol. 286, Iss. 1, 1995-11 ,pp. : 31-39

Elsevier

Access to resources Recommend Favorite